Antiangiogenic Agents Targeting Different Angiogenic Pathways Have Opposite Effects on Tumor Hypoxia in R-18 Human Melanoma Xenografts

BMC Cancer - United Kingdom
doi 10.1186/s12885-017-3404-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Alternative Angiogenic Pathways in Melanoma: The Role of AQP1

Journal of Solid Tumors
Cancer ResearchOncologyRadiologyNuclear MedicineImaging
2011English

The Influence of a Human Embryonic Stem Cell–Derived Microenvironment on Targeting of Human Solid Tumor Xenografts

Cancer Research
Cancer ResearchOncology
2006English

Antiangiogenic Therapy: A Novel Approach to Overcome Tumor Hypoxia

Chinese Journal of Cancer
2010English

Magnetic Resonance Imaging Identifies Early Effects of Sunitinib Treatment in Human Melanoma Xenografts

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2013English

Angiogenic and Antiangiogenic Gene Therapy

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2005English

Lack of Efficacy of Combined Antiangiogenic Therapies in Xenografted Human Melanoma

Journal of Oncology
Oncology
2012English

Targeting Inflammatory Pathways for Tumor Radiosensitization

Biochemical Pharmacology
BiochemistryPharmacology
2010English

Table 2: Anti-Tumor Agents for Targeting Hypoxia-Induced CA IX for Therapy and Diagnosis.

English

Targeting Protein-Trafficking Pathways Alters Melanoma Treatment Sensitivity

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy